This is again another example of where the future of preventative medicine is headed to, wearable technology. As the CEO of Apple, Tim Cooke, states “in the future people will look back at Apples greatest accomplishment being wearable medical tech.” This article outlines Apples partnership with Stanford university school of medicine and Johnson & Johnson on the specific goal of seeing if their watch can detect as early as possible AFIB (Atrial Fibulation). For us to truelly appreciate the magnitude of what this means let’s look into what AFIB is. According to the American Heart Association Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. At least 2.7 million Americans are living with AFib. About 15–20 percent of people who have strokes have this heart arrhythmia. This clot risk is why patients with this condition are put on blood thinners. Having this knowledge, the quote of Benjamin Franklin axiom says, “an ounce of prevention is worth a pound of cure” holds to be so accurate and true.

https://www.cardiovascularbusiness.com/topics/heart-failure/vest-aims-predict-prevent-mi-chf-patients